Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review

被引:44
作者
Mosheimer, Birgit A. [1 ]
Oppl, Bastian [2 ,3 ]
Zandieh, Shahin [4 ]
Fillitz, Michael [5 ]
Keil, Felix [5 ]
Klaushofer, Klaus [2 ,3 ]
Weiss, Guenter [1 ]
Zwerina, Jochen [2 ,3 ]
机构
[1] Med Univ Innsbruck, Dept Internal Med 4, Infect Dis Immunol Rheumatol Pneumol, Anichstr 35, Innsbruck, Austria
[2] Hanusch Hosp WGKK, Ludwig Boltzmann Inst Osteol, Vienna, Austria
[3] Hanusch Hosp, AUVA Trauma Ctr Meidling, Med Dept 1, Vienna, Austria
[4] Hanusch Hosp, Inst Radiol & Nucl Med, Vienna, Austria
[5] Hanusch Hosp, Med Dept 3, Vienna, Austria
关键词
Rosai-Dorfman disease; Bone involvement; Treatment strategies; LANGERHANS CELL HISTIOCYTOSIS; ERDHEIM-CHESTER-DISEASE; MASSIVE LYMPHADENOPATHY; SINUS HISTIOCYTOSIS; ASSOCIATION; DISORDERS;
D O I
10.1007/s11926-017-0656-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of Review Rosai-Dorfman disease (RDD) is a rare histiocytic disorder typically presenting as painless cervical lymphadenopathy. Extranodal involvement is common and may also affect bones. Here, we present a patient with typical nodal disease and multifocal bone manifestations. Further, a systematic literature review was performed to better understand the phenotype, clinical course and treatment options of such patients. Recent Findings RDD is a nonmalignant, classically sporadic histiocytosis. Nevertheless, increasing evidence also suggests familial forms of the disease. According to our literature review, bone involvement is exceedingly rare and heterogeneous. Clinical outcome in terms of mortality seems to be favorable in most cases. Currently, therapy strategies include surgical and immunosuppressive treatments, but the optimal treatment of osseous RDD remains to be defined. Summary Patients with osseous RDD may present to rheumatologists with arthralgia or arthritis. Due to the rarity of the disease, diagnosis and treatment remain challenging.
引用
收藏
页数:5
相关论文
共 18 条
[1]   Potential clinical implications of BRAF mutations in histiocytic proliferations [J].
Bubolz, Anna-Maria ;
Weissinger, Stephanie E. ;
Stenzinger, Albrecht ;
Arndt, Annette ;
Steinestel, Konrad ;
Bruederlein, Silke ;
Cario, Holger ;
Lubatschofski, Anneli ;
Welke, Claudia ;
Anagnostopoulos, Ioannis ;
Barth, Thomas F. E. ;
Beer, Ambros J. ;
Moeller, Peter ;
Gottstein, Martin ;
Viardot, Andreas ;
Lennerz, Jochen K. .
ONCOTARGET, 2014, 5 (12) :4060-4070
[2]   Rosai-Dorfman Disease: Tumor Biology, Clinical Features, Pathology, and Treatment [J].
Dalia, Samir ;
Sagatys, Elizabeth ;
Sokol, Lubomir ;
Kubal, Timothy .
CANCER CONTROL, 2014, 21 (04) :322-327
[3]   Primary Rosai-Dorfman Disease of Bone A Clinicopathologic Study of 15 Cases [J].
Demicco, Elizabeth G. ;
Rosenberg, Andrew E. ;
Bjornsson, Johannes ;
Rybak, Leon D. ;
Unni, K. Krishnan ;
Nielsen, G. Petur .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (09) :1324-1333
[4]  
Emile JF, 2016, BLOOD
[5]  
FOUCAR E, 1990, SEMIN DIAGN PATHOL, V7, P19
[6]   Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation [J].
Hervier, Baptiste ;
Haroche, Julien ;
Arnaud, Laurent ;
Charlotte, Frederic ;
Donadieu, Jean ;
Neel, Antoine ;
Lifermann, Francois ;
Villabona, Carles ;
Graffin, Bruno ;
Hermine, Olivier ;
Rigolet, Aude ;
Roubille, Camille ;
Hachulla, Eric ;
Carmoi, Thierry ;
Bezier, Maud ;
Meignin, Veronique ;
Conrad, Marie ;
Marie, Laurence ;
Kostrzewa, Elise ;
Michot, Jean-Marie ;
Barete, Stephane ;
Taly, Valerie ;
Cury, Karine ;
Emile, Jean-Francois ;
Amoura, Zahir .
BLOOD, 2014, 124 (07) :1119-1126
[7]   Venorelbine and methotrexate for the treatment of Rosai-Dorfman disease [J].
Inoue, S ;
Onwuzurike, N .
PEDIATRIC BLOOD & CANCER, 2005, 45 (01) :84-85
[8]   Erdheim-Chester disease: Evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis [J].
Kenn, W ;
Eck, M ;
Allolio, B ;
Jakob, F ;
Illg, A ;
Marx, A ;
Mueller-Hermelink, HK ;
Hahn, D .
HUMAN PATHOLOGY, 2000, 31 (06) :734-739
[9]  
McClain Kenneth L, 2004, Hematology Am Soc Hematol Educ Program, P283
[10]   A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? [J].
Menon, Madhu P. ;
Evbuomwan, Moses O. ;
Rosai, Juan ;
Jaffe, Elaine S. ;
Pittaluga, Stefania .
HISTOPATHOLOGY, 2014, 64 (03) :455-459